Cargando…

Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia

Background: Methylmalonic acidemia (MMA) is an autosomal recessive disorder treated with precursor-free medical food while limiting natural protein. This retrospective chart review was to determine if there was a relationship between medical food, valine (VAL) and/or isoleucine (ILE) supplementation...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, Laurie E., Burns, Casey, Drumm, Morgan, Gaughan, Sommer, Sailer, Melissa, Baker II, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071216/
https://www.ncbi.nlm.nih.gov/pubmed/32069872
http://dx.doi.org/10.3390/nu12020473
_version_ 1783506150650544128
author Bernstein, Laurie E.
Burns, Casey
Drumm, Morgan
Gaughan, Sommer
Sailer, Melissa
Baker II, Peter R.
author_facet Bernstein, Laurie E.
Burns, Casey
Drumm, Morgan
Gaughan, Sommer
Sailer, Melissa
Baker II, Peter R.
author_sort Bernstein, Laurie E.
collection PubMed
description Background: Methylmalonic acidemia (MMA) is an autosomal recessive disorder treated with precursor-free medical food while limiting natural protein. This retrospective chart review was to determine if there was a relationship between medical food, valine (VAL) and/or isoleucine (ILE) supplementation, total protein intake, and plasma amino acid profiles. Methods: A chart review, of patients aged 31 days or older with MMA treated with dietary intervention and supplementation of VAL and/or ILE and followed at the Children’s Hospital Colorado Inherited Metabolic Diseases Clinic. Dietary prescriptions and plasma amino acid concentrations were obtained at multiple time points. Results: Baseline mean total protein intake for five patients was 198% of Recommended Dietary Allowance (RDA) with 107% natural protein and 91% medical food. Following intervention, total protein intake (p = 0.0357), protein from medical food (p = 0.0142), and leucine (LEU) from medical food (p = 0.0276) were lower, with no significant change in natural protein intake (p = 0.2036). At baseline, 80% of patients received VAL supplementation and 100% received ILE supplementation. After intervention, only one of the cohort remained on supplementation. There was no statistically significant difference in plasma propiogenic amino acid concentrations. Conclusions: Decreased intake of LEU from medical food allowed for discontinuation of amino acid supplementation, while meeting the RDA for protein.
format Online
Article
Text
id pubmed-7071216
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70712162020-03-19 Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia Bernstein, Laurie E. Burns, Casey Drumm, Morgan Gaughan, Sommer Sailer, Melissa Baker II, Peter R. Nutrients Article Background: Methylmalonic acidemia (MMA) is an autosomal recessive disorder treated with precursor-free medical food while limiting natural protein. This retrospective chart review was to determine if there was a relationship between medical food, valine (VAL) and/or isoleucine (ILE) supplementation, total protein intake, and plasma amino acid profiles. Methods: A chart review, of patients aged 31 days or older with MMA treated with dietary intervention and supplementation of VAL and/or ILE and followed at the Children’s Hospital Colorado Inherited Metabolic Diseases Clinic. Dietary prescriptions and plasma amino acid concentrations were obtained at multiple time points. Results: Baseline mean total protein intake for five patients was 198% of Recommended Dietary Allowance (RDA) with 107% natural protein and 91% medical food. Following intervention, total protein intake (p = 0.0357), protein from medical food (p = 0.0142), and leucine (LEU) from medical food (p = 0.0276) were lower, with no significant change in natural protein intake (p = 0.2036). At baseline, 80% of patients received VAL supplementation and 100% received ILE supplementation. After intervention, only one of the cohort remained on supplementation. There was no statistically significant difference in plasma propiogenic amino acid concentrations. Conclusions: Decreased intake of LEU from medical food allowed for discontinuation of amino acid supplementation, while meeting the RDA for protein. MDPI 2020-02-13 /pmc/articles/PMC7071216/ /pubmed/32069872 http://dx.doi.org/10.3390/nu12020473 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bernstein, Laurie E.
Burns, Casey
Drumm, Morgan
Gaughan, Sommer
Sailer, Melissa
Baker II, Peter R.
Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title_full Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title_fullStr Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title_full_unstemmed Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title_short Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Methylmalonic Acidemia
title_sort impact on isoleucine and valine supplementation when decreasing use of medical food in the nutritional management of methylmalonic acidemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071216/
https://www.ncbi.nlm.nih.gov/pubmed/32069872
http://dx.doi.org/10.3390/nu12020473
work_keys_str_mv AT bernsteinlauriee impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia
AT burnscasey impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia
AT drummmorgan impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia
AT gaughansommer impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia
AT sailermelissa impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia
AT bakeriipeterr impactonisoleucineandvalinesupplementationwhendecreasinguseofmedicalfoodinthenutritionalmanagementofmethylmalonicacidemia